Skip to main content
. 2021 Jun 25;10(7):1028. doi: 10.3390/antiox10071028

Figure 9.

Figure 9

Sensitivity analysis for primary outcome qualitative pain reduction assessment (VAS score) from baseline up to the final follow-up timepoint.